Inclusion Criteria:  Study subjects, or their parent/legal guardian for subjects <18 years, must be able to understand the purpose and risks of the study and to provide signed and dated informed consent and authorization to use confidential health information in accordance with national and local subject privacy regulations. Subjects between the ages of 7 and 17.9 years must provide assent. Male or Female aged 7 years to 39 years. Diagnosed with Hodgkin or Non-Hodgkin Lymphoma. Scheduled treatment with cytotoxic chemotherapy with an associated high/intermediate risk of neutropenia. Able (in the Investigators's opinion) and willing to comply with all study requirements.  Exclusion Criteria:  Participants with amputations, congenital malformations, or any severe abnormalities of the hands as determined by the investigator. Participants with a history of vasculitis, Raynaud syndrome, scleroderma, mixed connective tissue disease, or any other rheumatologic systemic condition that could produce microcirculatory changes in the nailfold. Participants with circulating tumor cells in previous or current lab determinations. Participants with leukemia. Participants with any condition producing significant tremor (e.g., essential tremor, Parkinson´s disease, dystonic tremor). Unstable participants or participants with hypotension (systolic blood pressure <90 and diastolic blood pressure < 60mmHg). Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.